SEC 13F Intelligence

King Luther Capital Management Corp / TMO

King Luther Capital Management Corp’s Thermo Fisher Scientific Inc Position

Does King Luther Capital Management Corp own Thermo Fisher Scientific Inc (TMO)? Yes709.5K shares worth $349M (+1.51% of its 13F portfolio) as of Q1 2026, up from 688.4K shares the prior filed quarter.

Position Value
$349M
Q1 2026
Shares
709.5K
% of Portfolio
+1.51%
Quarters Held
30
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $297MQ4 ’18Q1 ’19: $356MQ2 ’19: $381MQ3 ’19: $377MQ4 ’19: $420MQ4 ’19Q1 ’20: $343MQ2 ’20: $436MQ3 ’20: $522MQ4 ’20: $528MQ4 ’20Q1 ’21: $477MQ2 ’21: $521MQ3 ’21: $584MQ4 ’21: $671MQ4 ’21Q1 ’22: $558MQ2 ’22: $504MQ3 ’22: $468MQ4 ’22: $502MQ4 ’22Q1 ’23: $522MQ2 ’23: $460MQ3 ’23: $443MQ4 ’23: $432MQ4 ’23Q1 ’24: $466MQ2 ’24: $438MQ3 ’24: $488MQ4 ’24: $406MQ4 ’24Q1 ’25: $382MQ2 ’25: $298MQ3 ’25: $330MQ4 ’25: $399MQ4 ’25Q1 ’26: $349Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026709.5K$349M+1.51%
Q4 2025688.4K$399M+1.62%
Q3 2025680.1K$330M+1.36%
Q2 2025734.0K$298M+1.29%
Q1 2025768.4K$382M+1.77%
Q4 2024779.8K$406M+1.76%
Q3 2024789.2K$488M+2.10%
Q2 2024791.8K$438M+1.97%
Q1 2024802.0K$466M+2.10%
Q4 2023814.3K$432M+2.08%
Q3 2023874.6K$443M+2.30%
Q2 2023882.2K$460M+2.29%
Q1 2023905.8K$522M+2.76%
Q4 2022911.4K$502M+2.75%
Q3 2022923.3K$468M+2.80%
Q2 2022927.2K$504M+2.82%
Q1 2022945.5K$558M+2.72%
Q4 20211.01M$671M+3.03%
Q3 20211.02M$584M+2.87%
Q2 20211.03M$521M+2.55%
Q1 20211.04M$477M+2.56%
Q4 20201.13M$528M+2.97%
Q3 20201.18M$522M+3.29%
Q2 20201.20M$436M+3.02%
Q1 20201.21M$343M+2.97%
Q4 20191.29M$420M+2.80%
Q3 20191.29M$377M+2.74%
Q2 20191.30M$381M+2.78%
Q1 20191.30M$356M+2.72%
Q4 20181.33M$297M+2.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See King Luther Capital Management Corp’s full portfolio or all institutional holders of TMO.